Dr. Sanaa Musa : Organic Synthesis and Medicinal Chemistry

Our research group focuses on the design and synthesis of hybrid molecules as potential candidates for innovative drug development.

Our current research areas include:

• Development of nitric oxide (NO) and hydrogen sulfide (H₂S) hybrid donor compounds based on a cannabinoid scaffold, exploring their dual activity in cardiovascular and neurodegenerative diseases.

   

• Synthesis of Schiff base–cannabinoid hybrid compounds and evaluation of their biological effects on the melanogenesis process.

   

• Development of platinum-based hybrid complexes with a particular emphasis on their potential as anti-cancer agents (in collaboration with Prof. Jamal Mahajna).

   

• Microencapsulation technology for bioactive compounds, focusing on their stability and controlled release to enhance the shelf life of various food products.